First Light Asset Management, LLC
Q1 2014 13F-HR Holdings
Net value change ($000)
+23,222
(19.7%)
New positions
9
Sold out positions
5
Turnover %
29.1%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q4 2013
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| IGI LABS INC | 6,406 | NEW |
| HBIO | 4,557 | NEW |
| ENZO BIOCHEM INC | 4,383 | NEW |
| Oxford Immunotec Global PLC | 3,519 | NEW |
| TECHNE CORP | 2,896 | NEW |
| SPECTRUM PHARMACEUTICALS INC | 2,738 | NEW |
| SPECTRANETICS CORP COM | 2,262 | 38.0% |
| NXSTAGE MEDICAL INC | 2,238 | NEW |
| LGND | 1,551 | 48.9% |
| Novadaq Technologies | 1,505 | 53.7% |
Top Reduces (Value $000, Stocks/ETFs)
| TEARLAB CORP COM | -4,753 | -100.0% |
| VOLCANO CORP | -3,313 | -100.0% |
| *ACCELRYS INC | -2,988 | -100.0% |
| ATRC | -2,543 | -22.7% |
| ARTHROCARE CORP | -1,771 | -100.0% |
| LANNETT CO INC | -1,074 | -23.1% |
| STKL | -617 | -16.8% |
| ENDO PHARMACEUTICALS HLDGS | -616 | -100.0% |
| CLDX | -469 | -16.7% |
| VIVUS INC | -194 | -21.9% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|